CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 83 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2018. The put-call ratio across all filers is 2.06 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $566,947,000 | -23.5% | 4,788 | -23.7% | 0.00% | – |
| Q4 2020 | $741,495,000 | +6.3% | 6,278 | 0.0% | 0.00% | – |
| Q3 2020 | $697,737,000 | +91.3% | 6,278 | +75.9% | 0.00% | – |
| Q2 2020 | $364,783,000 | -5.3% | 3,570 | 0.0% | 0.00% | – |
| Q1 2020 | $385,310,000 | -7.3% | 3,570 | 0.0% | 0.00% | – |
| Q4 2019 | $415,477,000 | -58.9% | 3,570 | -59.6% | 0.00% | -100.0% |
| Q3 2019 | $1,012,029,000 | +169.6% | 8,841 | +124.4% | 0.00% | – |
| Q2 2019 | $375,387,000 | -87.6% | 3,939 | -88.2% | 0.00% | -100.0% |
| Q1 2019 | $3,035,888,000 | -81.0% | 33,270 | -84.2% | 0.00% | -85.7% |
| Q4 2018 | $15,996,059,000 | -2.7% | 210,724 | +2.6% | 0.01% | +16.7% |
| Q3 2018 | $16,433,920,000 | – | 205,424 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERNIER CAPITAL PARTNERS, LP | 149,457 | $11,773,000 | 6.29% |
| INDUS CAPITAL PARTNERS, LLC | 330,339 | $26,021,000 | 2.54% |
| Perpetual Ltd | 129,799 | $10,215,000 | 1.32% |
| Black Creek Investment Management Inc. | 396,525 | $31,234,000 | 1.18% |
| RUDMAN ERROL M | 28,701 | $2,261,000 | 1.10% |
| COMGEST GLOBAL INVESTORS S.A.S. | 635,752 | $50,078,000 | 1.09% |
| Antipodean Advisors LLC | 15,000 | $1,182,000 | 0.96% |
| Hillhouse Capital Management | 618,391 | $48,711,000 | 0.83% |
| JUPITER ASSET MANAGEMENT LTD | 215,866 | $17,004,000 | 0.49% |
| Temasek Holdings (Private) Ltd | 990,000 | $77,982,000 | 0.48% |